Invention Grant
- Patent Title: Pyrazolopyrazine and triazolopyrazine compounds for the treatment of infectious diseases
-
Application No.: US16247170Application Date: 2019-01-14
-
Publication No.: US10683299B2Publication Date: 2020-06-16
- Inventor: Xingchun Han , Xianfeng Lin , Hong Shen , Taishan Hu , Zhisen Zhang
- Applicant: Hoffmann-La Roche Inc.
- Applicant Address: US NJ Little Falls
- Assignee: HOFFMANN LA ROCHE INC.
- Current Assignee: HOFFMANN LA ROCHE INC.
- Current Assignee Address: US NJ Little Falls
- Agency: Genentech, Inc.
- Agent Richard G. A. Bone
- Main IPC: C07D487/04
- IPC: C07D487/04 ; C07D513/04 ; A61P31/20 ; C07D519/00
Abstract:
The present invention relates to compounds of the formula (I), or pharmaceutically acceptable salts, enantiomer or diastereomer thereof, wherein R1 to R4 and Q are as described above. The compounds may be useful for the treatment or prophylaxis of hepatitis B virus infection.
Public/Granted literature
- US20190248792A1 NOVEL PYRAZOLOPYRAZINE AND TRIAZOLOPYRAZINE COMPOUNDS FOR THE TREATMENT OF INFECTIOUS DISEASES Public/Granted day:2019-08-15
Information query
